Surmodics, Inc. recently announced early results from its PROWL registry study of a subset of 60 real-world patients with acute ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...

In 2003, the US Food and Drug Administration approved the SilverHawk Plaque Excision System (FoxHollow Technologies, Redwood City, CA). The system consists of a catheter with a mounted blade and ...

Based on the available literature, there are some arguments for plaque debulking in the periphery. The data available support the contention that the current device can be safely used and is ...